Burris TP - Search Results

1

Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.

Welch RD, Billon C, Losby M, Bedia-Diaz G, Fang Y, Avdagic A, Elgendy B, Burris TP, Griffett K. Welch RD, et al. Among authors: burris tp. Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.

2

A liver-selective LXR inverse agonist that suppresses hepatic steatosis.

Griffett K, Solt LA, El-Gendy Bel-D, Kamenecka TM, Burris TP. Griffett K, et al. Among authors: burris tp. ACS Chem Biol. 2013 Mar 15;8(3):559-67. doi: 10.1021/cb300541g. Epub 2012 Dec 27. ACS Chem Biol. 2013. PMID: 23237488

3

Nuclear receptors and their selective pharmacologic modulators.

Burris TP, Solt LA, Wang Y, Crumbley C, Banerjee S, Griffett K, Lundasen T, Hughes T, Kojetin DJ. Burris TP, et al. Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23457206 Free PMC article. Review.

4

The mammalian clock and chronopharmacology.

Griffett K, Burris TP. Griffett K, et al. Among authors: burris tp. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1929-34. doi: 10.1016/j.bmcl.2013.02.015. Epub 2013 Feb 13. Bioorg Med Chem Lett. 2013. PMID: 23481644 Free PMC article. Review.

5

Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.

Banerjee S, Wang Y, Solt LA, Griffett K, Kazantzis M, Amador A, El-Gendy BM, Huitron-Resendiz S, Roberts AJ, Shin Y, Kamenecka TM, Burris TP. Banerjee S, et al. Among authors: burris tp. Nat Commun. 2014 Dec 23;5:5759. doi: 10.1038/ncomms6759. Nat Commun. 2014. PMID: 25536025 Free PMC article.

6

Suppression of atherosclerosis by synthetic REV-ERB agonist.

Sitaula S, Billon C, Kamenecka TM, Solt LA, Burris TP. Sitaula S, et al. Among authors: burris tp. Biochem Biophys Res Commun. 2015 May 8;460(3):566-71. doi: 10.1016/j.bbrc.2015.03.070. Epub 2015 Mar 20. Biochem Biophys Res Commun. 2015. PMID: 25800870 Free PMC article.

7

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis.

Griffett K, Welch RD, Flaveny CA, Kolar GR, Neuschwander-Tetri BA, Burris TP. Griffett K, et al. Among authors: burris tp. Mol Metab. 2015 Feb 9;4(4):353-7. doi: 10.1016/j.molmet.2015.01.009. eCollection 2015 Apr. Mol Metab. 2015. PMID: 25830098 Free PMC article.

8

Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.

Flaveny CA, Griffett K, El-Gendy Bel-D, Kazantzis M, Sengupta M, Amelio AL, Chatterjee A, Walker J, Solt LA, Kamenecka TM, Burris TP. Flaveny CA, et al. Among authors: burris tp. Cancer Cell. 2015 Jul 13;28(1):42-56. doi: 10.1016/j.ccell.2015.05.007. Epub 2015 Jun 25. Cancer Cell. 2015. PMID: 26120082 Free PMC article.

9

Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism.

Wang Y, Billon C, Walker JK, Burris TP. Wang Y, et al. Among authors: burris tp. ACS Chem Neurosci. 2016 Feb 17;7(2):143-8. doi: 10.1021/acschemneuro.5b00159. Epub 2015 Dec 3. ACS Chem Neurosci. 2016. PMID: 26625251 Free PMC article.

10

Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease.

Griffett K, Burris TP. Griffett K, et al. Among authors: burris tp. Biochem Biophys Res Commun. 2016 Oct 21;479(3):424-428. doi: 10.1016/j.bbrc.2016.09.036. Epub 2016 Sep 25. Biochem Biophys Res Commun. 2016. PMID: 27680310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters